Will Sohickean
Equity research analyst · Leerink Partners
Earnings calls
1
Nov 12, 2026 – Nov 12, 2026
Stocks asked about
1
Questions
1
Firm rating actions
0
on these stocks, from news
Coverage
Companies whose earnings calls Will Sohickean asked questions on (from Lician's transcripts).
Questions on earnings calls
- NKTR earnings call · NEKTAR THERAPEUTICSNov 12, 2026 · 1 question
- 53:11
“I do have a follow-up to the Zenith AD2 study. So just on the adjustment that you guys did, does the addition of TCS cause a sample size change or a powering assumption change as well? What placebo plus TCS response are you guys assuming, and is there a cap or stratification…”
- 53:11
Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.
Leerink Partners rating actions on these stocks
From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Will Sohickean. We do not use licensed rating databases.
No rating action by Leerink Partners on these stocks in the headlines we store yet.